Key result
Updated algorithm with SPECT/CT and renally adjusted ratios expands non-biopsy ATTR-CM diagnosis.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
An updated algorithm for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy using bone-avid tracer cardiac SPECT/CT incorporating renally adjusted κ/λ ratios.
No takes yet. Share an insight, caveat, or question.
Sharmila Dorbala (2023) studied this question. An updated algorithm using bone-avid tracer cardiac SPECT/CT and renally adjusted κ/λ ratios expands indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: